Grant number: 107749 | Funding period: 2022 - 2026
Active
J Lin, DI Finkelstein, AJ Anderson, PY Lee, BV Bui, T Wijeratne, JE Alty, CTO Nguyen
2025-01-01
Over the last two decades, visual symptoms and retinal changes in Parkinson’s disease (PD) have emerged as important biomarkers. C..
P Trlin, J Gong, KKN Tran, VHY Wong, PY Lee, A Hoang, D Zhao, LC Beauchamp, JKH Lim, A Metha, KJ Barnham, DI Finkelstein, BV Bui, P Bedggood, CTO Nguyen
2024-12-01
Retinal hyperspectral imaging (HSI) is a non-invasive in vivo approach that has shown promise in Alzheimer’s disease. Parkinson’s ..
KKN Tran, PY Lee, DI Finkelstein, AM McKendrick, BN Nguyen, BV Bui, CTO Nguyen
2024-01-23
Background: Visual biomarkers of Parkinson's disease (PD) are attractive as the retina is an outpouching of the brain. Although in..
KKN Tran, VHY Wong, KA Vessey, DI Finkelstein, BV Bui, CTO Nguyen
2024-01-01
Background: Loss of substantia nigra dopaminergic cells and alpha-synuclein (α-syn)-rich intraneuronal deposits within the central..
R Mainzer, M Moreno-Betancur, C Nguyen, J Simpson, J Carlin, K Lee
2023-02-01
Introduction Observational studies in health-related research often aim to answer causal questions. Missing data are common in the..
KKN Tran, VHY Wong, A Hoang, DI Finkelstein, BV Bui, CTO Nguyen
2023-01-01
Abnormal alpha-synuclein (α-SYN) protein deposition has long been recognized as one of the pathological hallmarks of Parkinson’s d..
TD Zhang, SC Kolbe, LC Beauchamp, EK Woodbridge, DI Finkelstein, EL Burrows
2022-12-01
The prodromal phase of Parkinson’s disease (PD) is characterised by many non-motor symptoms, and these have recently been posited ..